Condition: Alzheimers Disease · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).
This description comes directly from the study's public registry record.
Reference Study ID Number: WN45447 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Banner Alzheimer?s Institute | Phoenix, Arizona, United States | Recruiting |
| Sun Valley Research Center, Inc. | Imperial, California, United States | Recruiting |
| Healthy Brain Clinic | Long Beach, California, United States | Recruiting |
| Oakland Clinical | Oakland, California, United States | Recruiting |
| Riverside Clinical | Riverside, California, United States | Recruiting |
| Cenexel California Neuroscience Research, LLC | Sherman Oaks, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| JEM Research LLC | Atlantis, Florida, United States | Recruiting |
| K2 Medical Research-Winter Garden | Clermont, Florida, United States | Recruiting |
| Visionary Investigators Network- Neurology Aventura | Miami, Florida, United States | Recruiting |
| Charter Research - Winter Park/Orlando | Orlando, Florida, United States | Recruiting |
| Conquest Research - Lake Nona | Orlando, Florida, United States | Recruiting |
+ 138 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07170150